This year marks the 50th anniversary of the Icahn School of Medicine at Mount Sinai. From a start-up with a first-year class of 36 students, the School is now a 1,200-student research, education, and innovation powerhouse that is ranked 13th among medical schools in the United States for National Institutes of Health funding and second among U.S. medical schools in funding per principal investigator by the Association of American Medical Colleges.
To commemorate this achievement, Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, and President for Academic Affairs, Mount Sinai Health System, was interviewed about the School’s commitment to innovation and discovery. Groundbreaking science and a firm commitment to patient care have been the School’s primary objectives for the past 50 years. Dr. Charney aims to continue this perspective into the future.
Says Dr. Charney, “It is our responsibility—the current leadership, faculty, and students—to build on that foundation so that in the next 50 years we accomplish what they did and change the lives of our patients.”